Anavex Life Sciences Corp (AVXL)

[PeterKarol]

It is indeed interesting how the new FDA approach to AD changes things and how the Big Pharma moves the focus from mild and moderate AD to “prevention”. This is accomplished though the device of doubtful biomarkers. If one realize that medicine distinguish the cause from symptoms and this has been perennial concept in its history then AD at this time is just a collection of symptoms but the MOA is MIA (pan intended). If I am not wrong the mouse model creates AD “sick” mouse by injecting plaque into its brain. A2-73 cured these mice in general. Then let’s extended our horizon by pointing to the fact that in 30% patients after death there is no plaque. Some healthy people do have plaque. This conundrum